Lieberman J A, Kane J M, Johns C A
Department of Psychiatry, Hillside Hospital, Long Island Jewish Medical Center, Glen Oaks, N.Y. 11004.
J Clin Psychiatry. 1989 Sep;50(9):329-38.
The advent of antipsychotic drugs represented a milestone in psychotherapeutics. Despite their proven efficacy, antipsychotic drugs are limited by side effects and treatment resistance in some patients. Since the introduction of chlorpromazine and the subsequent development of numerous neuroleptic compounds, there have been no significant qualitative advances in the clinical efficacy of antipsychotic drugs. Clozapine is an experimental neuroleptic with atypical properties. In clinical testing, this agent has shown superior antipsychotic efficacy in treatment-refractory schizophrenics and a more favorable extrapyramidal side effect profile in comparison with standard neuroleptics. Because clozapine represents a potential contribution to our therapeutic armamentarium, this article provides an overview of its pharmacology, efficacy, and methods of clinical utilization.
抗精神病药物的出现代表了心理治疗学上的一个里程碑。尽管抗精神病药物已被证实具有疗效,但在某些患者中,其受到副作用和治疗抵抗的限制。自从氯丙嗪问世以及随后众多抗精神病化合物的研发以来,抗精神病药物的临床疗效在质量上没有显著进展。氯氮平是一种具有非典型特性的实验性抗精神病药物。在临床试验中,与标准抗精神病药物相比,该药物在难治性精神分裂症患者中显示出卓越的抗精神病疗效,且锥体外系副作用较少。由于氯氮平对我们的治疗手段有潜在贡献,本文对其药理学、疗效及临床应用方法进行综述。